What is the dose and frequency of doxylamine (antihistamine)/pyridoxine (Vitamin B6)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Doxylamine/Pyridoxine Dosing for Nausea and Vomiting of Pregnancy

The recommended dose is doxylamine 10 mg/pyridoxine 10 mg (Diclegis/Diclectin) starting with 2 tablets at bedtime on Day 1, then titrating up to a maximum of 4 tablets daily based on symptom response using a specific escalation protocol. 1, 2

Standard Dosing Protocol

Initial dosing:

  • Day 1: Take 2 tablets (doxylamine 10 mg/pyridoxine 10 mg each) at bedtime 1, 3
  • If symptoms are controlled the next day, continue this dose 3

Titration schedule if symptoms persist:

  • Day 2: If symptoms persist, take 2 tablets at bedtime PLUS 1 tablet in the morning 3, 4
  • Day 3: If symptoms still persist, take 1 tablet in the morning, 1 tablet mid-afternoon, and 2 tablets at bedtime (total of 4 tablets daily) 3, 4
  • Maximum dose: 4 tablets per day (doxylamine 40 mg/pyridoxine 40 mg total) 1, 3, 4

Clinical Context

This combination is FDA-approved and recommended as first-line pharmacologic therapy for nausea and vomiting of pregnancy (NVP) by ACOG and the American Gastroenterological Association. 1, 2, 5 The delayed-release formulation allows for once-daily or divided dosing depending on symptom severity and timing 4.

Key advantages:

  • Only FDA Pregnancy Category A medication for NVP 4
  • Safety data from over 200,000 first-trimester exposures showing no increased risk of congenital malformations 5, 4
  • Well-tolerated with no increased adverse events compared to placebo 3

Important Caveats

Efficacy considerations:

  • The clinical benefit is modest, with improvement of approximately 0.7-1.25 points on the 13-point PUQE scale, which may not reach the minimal clinically important difference of 3 points 6
  • Despite limited magnitude of benefit, it remains first-line therapy due to proven safety profile and FDA approval 1, 2, 5

When this regimen fails:

  • For moderate-severe NVP not responding to maximum dose (4 tablets daily), escalate to metoclopramide or ondansetron (with caution before 10 weeks gestation) 1, 2
  • Consider hospitalization for IV hydration if severe symptoms persist 1, 2

Distinction from Pyridoxine Supplementation

This dosing is distinct from pyridoxine supplementation for other indications:

  • For prevention of isoniazid-induced peripheral neuropathy: pyridoxine 25 mg daily 7
  • For pregnant women on isoniazid: pyridoxine 25 mg daily (note: standard multivitamins contain insufficient amounts) 7
  • For patients with established peripheral neuropathy: pyridoxine 100 mg daily 7

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.